"While there is some skepticism among nurses, I believe that when applied in the right settings, artificial intelligence is far from a threat," says Hadassah Backman, CEO of Guardoc, a clinical data ...

Please provide your email address to receive an email when new articles are posted on . My role as the chief medical officer of an eye and vision HMO provides me with a unique window into the medical ...

Altera Digital Health embeds Quippe into new AI offering to modernize EHR workflows and convert multimodal provider inputs into structured, codified data "I've seen documentation requirements rise ...

Primary care physicians have been observed spending nearly 2 hours on EHR tasks per hour of direct patient care, underscoring how documentation burdens drive bu ...

Physiologic monitoring devices are so ubiquitous in hospitals that it’s difficult to recall a time without them. The success of integrating this technology into patient care as a regular part of the ...

MISSISSAUGA, Ont. - Bayshore Home Health is launching a mobile electronic charting program to help reduce costs, increase efficiencies and assist nurses and unregulated care providers in delivering a ...

The Seattle-based startup has been honored for a healthcare product that uses artificial intelligence to reduce the EHR documentation burden. SEATTLE--(BUSINESS WIRE)--Healthcare technology vendor, ...

Forbes contributors publish independent expert analyses and insights. That momentum continues today with the announcement of a $21 million Series A by Layer Health, an ambitious healthcare AI startup ...

Nada will enable healthcare providers save more than 50% time on clinical documentation and reclaim nearly two hours per ...

The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in this ...

Arcellx is a biotech firm developing advanced cell therapies for diseases like cancer, with a focus on their CART-ddBCMA program for multiple myeloma. Recent positive FDA developments have lifted the ...

The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in this ...